Internal Medicine, Cardiovascular Disease · Neptune, NJ
NPI
1861492027
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
444 Neptune Blvd
Neptune, NJ, 07753
Phone (732) 775-5300
Groups this clinician bills Medicare through
Medicare paid, 2024
$577K
8,577 services
Medicare patients, 2024
2,100
Average age 77
Drug cost, 2024
$3.1M
11,819 prescriptions
Company payments, 2025
$3,209
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kenneth B Harris was code 99214 (office e&m - established), 1,780 times for 945 patients. In total Kenneth B Harris billed 8,577 services in 63 codes, and Medicare paid $577K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-09-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,780 | 945 | $99.24 | $177K |
| 93000 Electrocardiogram | Office | 1,622 | 936 | $11.26 | $18K |
| 93010 Electrocardiogram | Facility | 1,046 | 694 | $6.69 | $7,000 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 673 | 606 | $13.86 | $9,328 |
| 99232 Hospital E&M - Subsequent | Facility | 530 | 214 | $66.34 | $35K |
| 99215 Office E&M - Established | Office | 467 | 331 | $136.92 | $64K |
| 93306 Echocardiography (TTE/TEE) | Office | 310 | 302 | $167.92 | $52K |
| 99233 Hospital E&M - Subsequent | Facility | 268 | 147 | $99.90 | $27K |
| 93356 Echocardiography (TTE/TEE) | Office | 265 | 259 | $32.27 | $8,550 |
| 93296 External Electrocardiographic Monitoring | Office | 157 | 67 | $17.67 | $2,774 |
| 93298 External Electrocardiographic Monitoring | Office | 141 | 26 | $71.30 | $10K |
| 99223 Hospital E&M - Initial | Facility | 133 | 128 | $143.81 | $19K |
| 93294 External Electrocardiographic Monitoring | Office | 124 | 54 | $22.49 | $2,789 |
| 93229 Electrocardiogram | Office | 119 | 116 | $718.42 | $85K |
| 93018 Electrocardiogram | Office | 114 | 114 | $11.51 | $1,312 |
By year: 2022 $584K for 6,362 services; 2023 $535K for 7,023 services; 2024 $577K for 8,577 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kenneth B Harris prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,061 prescriptions and refills. In total Kenneth B Harris wrote 11,819 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 1,061 | 3,042 | 316 | $16K |
| Amlodipine Besylate Generic | 761 | 2,158 | 224 | $5,405 |
| Atorvastatin Calcium Generic | 713 | 2,039 | 215 | $6,511 |
| Carvedilol Generic | 645 | 1,825 | 186 | $7,051 |
| Nebivolol Hcl Generic | 613 | 1,693 | 182 | $39K |
| Eliquis Apixaban | 562 | 1,232 | 139 | $693K |
| Hydrochlorothiazide Generic | 551 | 1,519 | 170 | $3,444 |
| Metoprolol Succinate Generic | 478 | 1,340 | 152 | $7,554 |
| Ezetimibe Generic | 459 | 1,312 | 146 | $12K |
| Losartan Potassium Generic | 344 | 969 | 107 | $3,919 |
| Telmisartan Generic | 312 | 877 | 89 | $12K |
| Valsartan Generic | 281 | 754 | 88 | $8,809 |
| Furosemide Generic | 229 | 587 | 80 | $1,445 |
| Lisinopril Generic | 219 | 596 | 64 | $1,629 |
| Irbesartan Generic | 194 | 554 | 55 | $4,096 |
Brand drugs: 1,963 claims; generic drugs: 9,856 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kenneth B Harris $3,209 ($3,209 in general payments such as food, travel and fees) from 22 companies. The largest payer was Novo Nordisk Inc with $439.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 17 | $439 |
| Amgen Inc. AMGN | 14 | $434 |
| Alnylam Pharmaceuticals Inc. ALNY | 12 | $334 |
| Novartis Pharmaceuticals Corporation NVS | 14 | $306 |
| BridgeBio Pharma, Inc. BBIO | 9 | $246 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $214 |
| Actelion Pharmaceuticals US, Inc. JNJ | 2 | $212 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $181 |
| E.R. Squibb & Sons, L.L.C. BMY | 13 | $161 |
| Heartflow, Inc. HTFL | 2 | $147 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.